Detalles de la búsqueda
1.
An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease.
Respirology
; 25 Suppl 2: 24-36, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33124087
2.
Quality of life in patients with lung cancer: the way forward.
Lancet Oncol
; 21(5): 617-619, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32213340
3.
Checkpoint inhibitors in older patients with advanced non-small cell lung cancer.
Crit Rev Oncol Hematol
; 188: 104056, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301272
4.
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.
Eur J Cancer
; 189: 112920, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37277262
5.
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
Front Immunol
; 14: 1289434, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38304255
6.
Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements.
Cancers (Basel)
; 14(3)2022 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158987
7.
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma.
Crit Rev Oncol Hematol
; 172: 103639, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35192932
8.
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients.
Crit Rev Oncol Hematol
; 169: 103536, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34801697
9.
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer.
Cells
; 11(20)2022 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291098
10.
Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
Immunotargets Ther
; 10: 9-26, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33575224
11.
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon.
Cancer Treat Rev
; 101: 102308, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34757306
12.
Repositioning PARP inhibitors in the treatment of thoracic malignancies.
Cancer Treat Rev
; 99: 102256, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261032
13.
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center.
Explor Target Antitumor Ther
; 2(5): 481-489, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-36045703
14.
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective.
Crit Rev Oncol Hematol
; 160: 103300, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744362
15.
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features.
Cancers (Basel)
; 13(12)2021 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34208253
16.
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations.
Cancers (Basel)
; 13(10)2021 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34067823
17.
Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era.
Lung Cancer
; 157: 85-91, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33994198
18.
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review.
Eur J Cancer
; 149: 49-60, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33823362
19.
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.
Crit Rev Oncol Hematol
; 157: 103189, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33341505
20.
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients.
Eur J Cancer
; 146: 74-83, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588147